# OnCo record 3sbio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/3sbio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "3sbio" ;
  schema:name "3SBio"@en ;
  schema:alternateName "Shenyang Sunshine Pharmaceutical"@en, "Sansheng Pharmaceutical"@en ;
  schema:description "3SBio is a Shenyang biologics company whose HER2 antibody inetetamab was approved in China in 2020 for HER2-positive metastatic breast cancer."@en ;
  schema:url <https://onco.cc/companies/3sbio/>, <https://www.3sbio.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.3sbio.com> ;
  onco:tag "ctgov-sponsor", "china" ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:drugs <https://onco.cc/drugs/inetetamab/>, <https://onco.cc/drugs/ssgj-612/>, <https://onco.cc/drugs/ssgj-705/>, <https://onco.cc/drugs/ssgj-706/> ;
  onco:trials <https://onco.cc/trials/nct07008703/>, <https://onco.cc/trials/nct07171606/>, <https://onco.cc/trials/nct07022002/>, <https://onco.cc/trials/nct07646626/> .